Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Takeda"

03:03 EDT 30th July 2014 | BioPortfolio

Original Source: Takeda Pharmaceutical Company Limited

1781 Founding Over two centuries ago in 1781, 32-year-old Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka, the center of the medicine trade in Japan. His small shop bought medicines from wholesalers, then divided them into smaller batches and sold them to local medicine merchants and doctors. This was the beginning of the present-day Takeda Chemical Industries, Ltd.

Matching Channels

Pertussis Vaccine acellular Takeda

Actos

Actos, produced by Takeda Pharmaceuticals North America, Inc netted $2.5m in sales in 2009, the 9th highest in the world. Actos is a type of thiazolidinediones, acting to increase sensitivity to I...

Prevacid

Prevacid, produced by Takeda Pharmaceuticals North America, Inc netted $2.5 in sales in 2009, the 10th highest in the world. Prevacid, the trade name for lansoprazole, is a proton pump inhibitor d...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Jury Finds for Takeda in Diabetes Drug Case Takeda Emphasizes Continued Commitment to Actos and Patient Safety

Deerfield, Ill., May 15, 2014, and Osaka, Japan, May 16, 2014 – Takeda Pharmaceutical Company Limited (“Takeda”) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc....

New Takeda CFO Takes Takeda Investor Search Abroad As Firm Goes Global

The recent influx of foreign executives at Takeda Pharmaceutical has led to a broadening of the firm's shareholder base to beyond its shores.

Takeda Submits a New Drug Application for TAK-438 in Japan for the Treatment of Acid-related Diseases

Osaka, Japan, February 28, 2014 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it has submitted a New Drug Application to the Ministry of Health, Labour and Welf...

Jury finds in favor of Takeda in diabetes drug Actos case

The US subsidiary of Japan’s largest drugmaker, Takeda Pharmaceuticals, yesterday announced that in the case of Bertha Triana and Delores Cipriano v Takeda, et al, No. A680556 the jury found in favo...

Takeda Submits NDA for TAK-438 in Japan

Takeda Pharmaceutical Co. Ltd. announced that it has submitted a New Drug Application (NDA) to the Ministry of Health, Labor and Welfare for TAK-438 (generic name: Vonoprazan Fumarate).

Takeda Well-Being Program 2013 - "Giving Children in Long-term Treatment the Energy to Live"

Osaka, Japan, February 27, 2014 – Takeda Pharmaceutical Company Limited (“Takeda”) today announced that the annual programs for the “Takeda Well-Being Program” have been...

Takeda ends Affymax deal, to pull Omontys NDA

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is ending a 2006 deal with Affymax Inc. (OTCQB:AFFY) to co-develop and co-commercialize Omontys peginesatide, effective Sept. 10. The pharma said it also wi...

Takeda Recognized as a Nadeshiko Brand, An Enterprise Encouraging Women's Success in the Workplace

Osaka, Japan, March 4, 2014 –Takeda Pharmaceutical Company Limited (Takeda) announced today that the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) have recogn...

Matching PubMed Articles

Laparoscopic Removal of a Congenital Seminal Vesicle Cyst in Zinner's Syndrome.

Seminal vesicle cysts are rarely diagnosed, but symptomatic congenital seminal vesicle cysts are reported in the literature describing Zinner syndrome. Case Description: We present the case of a 26-ye...

Vortioxetine for the treatment of major depression.

Vortioxetine (Lu-AA-21004; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine hydrobromide) is a novel orally active molecule that is being investigated by Lundbeck and Takeda for the treatment of maj...

World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.

The World Antibody-Drug Conjugate (WADC) Summits organized by Hanson Wade are currently the largest meetings fully dedicated to ADCs. The first global ADC Summit was organized in Boston in October 201...

Nucleophilic cross-linked, dextran coated iron oxide nanoparticles as basis for molecular imaging: synthesis, characterization, visualization and comparison with previous product.

We present a new synthesis protocol for a multivalent, multimodality, nucleophilic nanoparticle ideal for in vivo imaging. Stability requirements necessitated covalent cross-linking of the carbohydrat...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement